Clinical Trials Logo

Fibrocystic Disease of Breast clinical trials

View clinical trials related to Fibrocystic Disease of Breast.

Filter by:
  • None
  • Page 1

NCT ID: NCT02929420 Recruiting - Clinical trials for Fibrocystic Disease of Breast

A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule

Start date: October 2016
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Xiaoru Sanjie capsule in the treatment of cyclomastopathy.

NCT ID: NCT00999921 Completed - Clinical trials for Benign Breast Disease

Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

Start date: January 2008
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine the efficacy and relapse rate of low dose, short duration treatment with tamoxifen in benign breast disease amenable to hormonal therapy with respect to etiology and estrogen receptor status and to realize its side-effects and cost of therapy. To do a comparative analysis of the results with evening primrose oil which is one of the first line management in benign breast disease.

NCT ID: NCT00826488 Completed - Breast Cancer Clinical Trials

A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses

Start date: March 2009
Phase: Phase 0
Study type: Interventional

The purpose of this study is to compare conventional breast imaging and diagnostic work-up (2 dimensional imaging) to digital breast tomosynthesis (3 dimensional imaging) in the appearance of non-calcified breast masses. It is thought that non-calcified breast masses will be better visualized with the new 3D technology.

NCT ID: NCT00744276 Completed - Clinical trials for Fibrocystic Disease of Breast

A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease

FP1198-001
Start date: January 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety of three doses of topically applied danazol compared to placebo in subjects with pain associated with fibrocystic breast disease and to determine the appropriate clinical dose for future studies.

NCT ID: NCT00310882 Withdrawn - Breast Neoplasms Clinical Trials

Involvement of Endogenous Digitalis-like Compounds in Breast Cancer

Start date: May 2006
Phase: N/A
Study type: Observational

The endogenous digitalis-like compounds (DLC)are steroid hormones synthesized and released from the adrenal gland.They are integrated in the feed-back system of the Hypothalami-Pituitary-Adrenal gland axis.One of their remarkable function is to induce apoptosis in malignant cells. Recently, accumulating data point to the possibility of using synthetic DLC as new anti-cancer drugs. Less is known about the endogenous metabolism of these compounds in cancer patients. Proceeding from preliminary clinical data which demonstrated significantly reduced DLC plasma levels in breast cancer patients and from in vitro data which showed an impaired release of DLC towards stress stimuli in athymic nude mice,we put up the hypothesis that a latent adrenal insufficiency with low DLC levels facilitates the induction and progression of tumor diseases.

NCT ID: NCT00237523 Active, not recruiting - Pain Clinical Trials

Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain

Start date: July 2005
Phase: Phase 3
Study type: Interventional

- History of clinical breast pain for at least the last six months. - At least six days of moderate or severe breast pain per cycle. - Fibrosis, cysts, nodules involving at least 25% of the surface of one breast. - Euthyroid with no prior history of thyroid disease. - Six months of daily therapy with molecular iodine. - Placebo controlled vs active (1:1).